Form 4 Filing: Wilson Martin Sells $256K of $RCKT

INSIDER SALE

⚡ MATERIALITY: 5/10

corporate issuer

ROCKET PHARMACEUTICALS, INC.

Ticker: $RCKT

Transaction Value

$256K

Price/Share: $3.40

transaction date

2026-09-11

Shares: 75,364

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wilson Martin, holds the title of General Counsel at ROCKET PHARMACEUTICALS, INC..

On 2026-09-11, the insider transacted 75,364 shares.The shares were transacted at a weighted average price of $3.40 per share, resulting in a total market-relevant value of $256K.

Executive Summary Summary

Wilson Martin (General Counsel) sold $256K of $RCKT

Post-Transaction Position: 598,489 shares

SEC Accession No: 0001140361-26-036688 (CIK: 1704342)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$RCKT Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$RCKT News Coverage